Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors | Nature Biotechnology
Developing and evaluating polygenic risk prediction models for stratified disease prevention | Nature Reviews Genetics
Genetics of coronary artery disease: discovery, biology and clinical translation | Nature Reviews Genetics
An analysis of genetic heterogeneity in untreated cancers | Nature Reviews Cancer
Genomics of hypertension: the road to precision medicine | Nature Reviews Cardiology
Nutrients | Free Full-Text | Genetics of Type 2 Diabetes: Past, Present, and Future
A decade of advances in transposon-insertion sequencing | Nature Reviews Genetics
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes | Nature Reviews Molecular Cell Biology
Developing and evaluating polygenic risk prediction models for stratified disease prevention | Nature Reviews Genetics
Navigating the pitfalls of mapping DNA and RNA modifications | Nature Reviews Genetics
The NIH Somatic Cell Genome Editing program | Nature
The Genetics of Stress-Related Disorders: PTSD, Depression, and Anxiety Disorders | Neuropsychopharmacology
Genome-wide associations for birth weight and correlations with adult disease | Nature
Learning from Nature to Expand the Genetic Code: Trends in Biotechnology
Spatial biology of cancer evolution | Nature Reviews Genetics
Induced protein degradation: an emerging drug discovery paradigm | Nature Reviews Drug Discovery
Genetic testing for cancer susceptibility: the promise and the pitfalls | Nature Reviews Cancer
Developing and evaluating polygenic risk prediction models for stratified disease prevention | Nature Reviews Genetics
RNA-binding proteins in human genetic disease | Nature Reviews Genetics
Improving reporting standards for polygenic scores in risk prediction studies | Nature
Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes | Nature Communications
Modeling uniquely human gene regulatory function via targeted humanization of the mouse genome | Nature Communications
Translating polygenic risk scores for clinical use by estimating the confidence bounds of risk prediction | Nature Communications
Reprogramming the genetic code | Nature Reviews Genetics
African genetic diversity and adaptation inform a precision medicine agenda | Nature Reviews Genetics
The personal and clinical utility of polygenic risk scores | Nature Reviews Genetics
